Three cases of zolpidem dependence treated with fluoxetine: The serotonin hypothesis

World Journal of Biological Psychiatry

Volumn 4, Issue 2, 2003, Pages 93-96

  Liappas, Ioannis A ^a   Malitass, Petros N ^a   Dimopouloss, Nikolaos P ^b   Gitsas, Olympia E ^c   Liappass, Alexandros I ^d   Nikolaous, Chrisoula K ^a   Christodoulous, Georgios N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

abuse; dependence; fluoxetine; zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; FLUOXETINE; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; ZOLPIDEM;

ADDICTION; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; METABOLISM; TREATMENT OUTCOME;

ADULT; FEMALE; FLUOXETINE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PYRIDINES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 0043288642     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970309167957     Document Type: Article

References (17)

1. Aragona M (2000) Abuse, dependence, and epileptic seizures after Zolpidem withdrawal: Review and case report. Clin Neuropharmacol 23:281-283.
2. Benavides J, Depoortere H, Sanger D, Perrault G, Arbilla S, Langer SZ, Zivkovic B, Scatton B (1990) Un domaine specifique (site to,) du recepteur GABAA pourrait etre implique dans les effets hypnotiques du Zolpidem. L 'Encephale 16:13-22.
3. Buhot M, Martin S, Segu L (2000) Role of serotonin in memory impairment. Ann Med 32:210-221.
4. Courtet P, Pignay V, Castelnau D, Boulenger JP (1999) Abus et dependance au Zolpidem: a propos de sept cas. L 'Encephale 25:652-657.
5. Gericke C, Ludolph A (1994) Chronic abuse of Zolpidem. JAMA 272:1721-1722.
6. Golden S, Vagnoni C (2000) Zolpidem dependence and prescription fraud. Am J Addict 9:96-97.
7. Heninger G (2000) Antidepressants. New Oxford Textbook of Psychiatry. Oxford University Press, New York, pp 1293-1305.
8. Holm K, Goa K (2000) Zolpidem An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59:865-889.
9. Kelsey J, Nemeroff C (2000) Fluoxetine. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Lippincott Williams & Wilkins, Philadelphia, pp 2438-2444.
10. A-receptor subtypes: Clinical efficacy and selectivity of benzodiazepine site ligands. Ann Med 29:275-282.
11. Koyama S, Kubo C, Rhee JS, Akaike N (1999) Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. J Physiol 518:525-538.
12. A receptors in the regulation of sleep: Initial sleep responses to peripherally administrated modulators and agonists. Sleep 22:33-41.
13. Langtry H, Benfield P (1990) Zolpidem A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40:291-313.
14. Mitler M (2000) Nonselective and selective benzodiazepine receptor agonists - where are we today? Sleep 23(Suppl 1):39-46.
15. Nutt D (1996) Addiction: brain mechanisms and their treatment implications. Lancet 347:31-36.
16. Ravishankar A, Carnwath T (1998) Zolpidem tolerance and dependence - two case reports. J Psychopharmacol 12:103-104.
17. Scatton B, Claustre Y, Dennis T, Nishikawa T (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cGMP and cerebral monoamines. J Pharm Exp Ther 237:659-665.